Melt Pharmaceuticals, Inc. Contracts & Agreements

19 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement, dated December 11, 2018, by and between the Registrant and Imprimis Pharmaceuticals, Inc
Purchase Agreements
Melt Pharmaceuticals, Inc.
Pharmaceuticals
CA
2022
Registrants 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Melt Pharmaceuticals, Inc.
Pharmaceuticals
2022
Form of Stock Option Grant Notice and Option Agreement under 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Melt Pharmaceuticals, Inc.
2022
Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Melt Pharmaceuticals, Inc.
Pharmaceuticals
2022
Form of Non-Employee Director Deferred Issuance Restricted Stock Unit Grant Notice and Non-Employee Director Deferred Issuance Restricted Stock Unit Award Agreement under 2018...
Bonus & Incentive Agreements
Melt Pharmaceuticals, Inc.
Pharmaceuticals
2022
Form of Non-Employee Director and Officer Restricted Stock Unit Grant Notice and Non-Employee Director and Officer Restricted Stock Unit Award Agreement under 2018 Equity...
Bonus & Incentive Agreements
Melt Pharmaceuticals, Inc.
Pharmaceuticals
2022
Loan and Security Agreement, dated September 1, 2021, by and between the Registrant and Harrow Health, Inc
Loan Agreements
Melt Pharmaceuticals, Inc.
Pharmaceuticals
DE
2022
Amendment to Loan and Security Agreement, dated April 8, 2022, by and between the Registrant and Harrow Health, Inc
Loan Agreements
Melt Pharmaceuticals, Inc.
2022
Patent Security Agreement, dated September 1, 2021, by and between the Registrant and Harrow Health, Inc
Security Agreements
Melt Pharmaceuticals, Inc.
Pharmaceuticals
DE
2022
Trademark Security Agreement, dated September 1, 2021, by and between the Registrant and Harrow Health, Inc
Security Agreements
Melt Pharmaceuticals, Inc.
Pharmaceuticals
DE
2022
Right of First Refusal Agreement, dated September 1, 2021, by and between the Registrant and Harrow Health, Inc
Melt Pharmaceuticals, Inc.
2022
Management Services Agreement, dated February 1, 2019, by and between the Registrant an Harrow Health, Inc
Management Agreements
Melt Pharmaceuticals, Inc.
2022
Royalty Agreement, dated October 3, 2019, by and between the Registrant and OHSO, LLC
Melt Pharmaceuticals, Inc.
Pharmaceuticals
2022
Offer Letter, dated June 18, 2021, by and between the Registrant and Larry Dillaha, M.D
Melt Pharmaceuticals, Inc.
Pharmaceuticals
2022
Offer Letter, dated September 27, 2018, by and between the Registrant and Gregory Madison
Melt Pharmaceuticals, Inc.
2022
Offer Letter, dated April 29, 2019, by and between the Registrant and Mark Hazard
Melt Pharmaceuticals, Inc.
2022
Offer Letter, dated February 18, 2022, by and between the Registrant and D. Bradford Osborne
Melt Pharmaceuticals, Inc.
2022
Letter of Termination and Release Agreement, dated May 28, 2021, by and between the Registrant and Mark Hazard
Termination Agreements
Melt Pharmaceuticals, Inc.
Pharmaceuticals
2022
Second Amendment to Loan and Security Agreement, dated September 21, 2022, by and between the Registrant and Harrow Health, Inc
Loan Agreements
Melt Pharmaceuticals, Inc.
Pharmaceuticals
DE
2022